ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Maleic Acid → HCID 178488223、化合物

HRID 897601
印刷

反応式

HRID 897601 の反応式
[NH2:1][C:2]1[N:7]=[CH:6][N:5]=[C:4]2[N:8]([C@H:30]3[CH2:35][CH2:34][C@H:33]([N:36]4[CH2:41][CH2:40][N:39]([CH3:42])[CH2:38][CH2:37]4)[CH2:32][CH2:31]3)[N:9]=[C:10]([C:11]3[CH:16]=[CH:15][C:14]([NH:17][C:18](=[O:27])[CH2:19][CH2:20][C:21]4[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=4)=[C:13]([O:28][CH3:29])[CH:12]=3)[C:3]=12.[C:43]([OH:50])(=[O:49])/[CH:44]=[CH:45]\[C:46]([OH:48])=[O:47]>C(OCC)(=O)C>[C:43]([OH:50])(=[O:49])/[CH:44]=[CH:45]\[C:46]([OH:48])=[O:47].[C:43]([OH:50])(=[O:49])/[CH:44]=[CH:45]\[C:46]([OH:48])=[O:47].[C:43]([OH:50])(=[O:49])/[CH:44]=[CH:45]\[C:46]([OH:48])=[O:47].[NH2:1][C:2]1[N:7]=[CH:6][N:5]=[C:4]2[N:8]([C@H:30]3[CH2:31][CH2:32][C@H:33]([N:36]4[CH2:37][CH2:38][N:39]([CH3:42])[CH2:40][CH2:41]4)[CH2:34][CH2:35]3)[N:9]=[C:10]([C:11]3[CH:16]=[CH:15][C:14]([NH:17][C:18](=[O:27])[CH2:19][CH2:20][C:21]4[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=4)=[C:13]([O:28][CH3:29])[CH:12]=3)[C:3]=12
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 444266Maleic AcidHCID 178488222HCID 178488222、化合物

生成物 1

HCID 178488223HCID 178488223、化合物

試薬・触媒・溶媒 1

HCID 8857Ethyl Acetate溶媒2 回

実験手順

Tetrakis(triphenylphosphine)palladium (0.035 g, 0.03 mmol) was added and the mixture stirred over night (15 h). The organic layer was removed under reduced pressure, and ethyl acetate was added. The layers were partitioned, and the aqueous layer was extracted with ethyl acetate (300 mL). The combined organic layers were washed with water and brine, dried over magnesium sulfate, filtered and evaporated under reduced pressure. The crude material was purified by flash chromatography on silica gel, using 10% methanol in dichloromethane (6 L) as eluent. A second purification on a Supelco flash chromatography column was required, using 20% methanol in dichloromethane as eluent. The second column afforded 0.132 g (38%) of trans-N1-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-3-phenylpropanamide. The product was sent for preparative HPLC purification (Hypersil C18, 100×21 mm column, 5 μm, 15-100% Acetonitrile gradient over 8 min, total run time—10 min, buffer—50 mM Ammonium Acetate, 25 ml/min), and afforded 0.026 g of trans-N1-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-3-phenylpropanamide. A warm solution of trans-N1-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-3-phenylpropanamide (0.026 g, 0.046 mmol) in ethyl acetate was treated with a warm solution of maleic acid (0.016 g, 0.137 mmol) in ethyl acetate. The precipitate was filtered under nitrogen atmosphere and dried under high vacuum to give trans-N1-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-3-phenylpropanamide tris-maleate.

後処理

  1. filtrationThe precipitate was filtered under nitrogen atmosphere
  2. customdried under high vacuum

出典と根拠

ORDレコード
ord-550e997270b3442793dd574508d65cae
出典データセット
uspto-grants-2005_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06921763B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート